AMANDA MCMASTERS: Open Payments
NPI 1467970657 · DUNCAN, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$547 in 32 payments from 11 companies in 2025. Trend: 2023 $474 · 2024 $1,097 · 2025 $547
Food & beverage: $547
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $91 |
| GENZYME CORPORATION | 4 | $86 |
| INOGEN, INC. | 5 | $79 |
| GlaxoSmithKline, LLC. | 4 | $76 |
| Verona Pharma, Inc. | 4 | $63 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| Kestra Medical Technology Services, Inc. | 1 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $19 |
Products named: FASENRA, DUPIXENT, INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH, Ohtuvayre, NUCALA, Assure WCD, GLASSIA, LEQVIO.
Industry payments across OK — which companies pay providers there.
